Tech Company Financing Transactions
Achaogen Funding Round
Arch Venture Partners invested in a $2.2 million funding round for Achaogen. The round was announced on 9/30/2010.
Transaction Overview
Company Name
Announced On
9/30/2010
Transaction Type
Venture Equity
Amount
$2,232,000
Round
Undisclosed
Investors
Arch Venture Partners (Kristina Burow)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1 Tower Pl. 400
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Achaogen is dedicated to addressing serious medical needs caused by the development of bacterial resistance to antibiotics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Blake Wise
Browse more venture capital transactions:
Prev: 9/30/2010: Nfocus Neuromedical venture capital transaction
Next: 9/30/2010: Active Endpoints venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs